How Much Longer Will We Put Up With $100,000 Cancer Drugs?

Workman, Paul; Draetta, Giulio F; Schellens, Jan H M; Bernards, René

doi:https://doi.org/10.1016/j.cell.2017.01.034

How Much Longer Will We Put Up With $100,000 Cancer Drugs?

DSpace/Manakin Repository

How Much Longer Will We Put Up With $100,000 Cancer Drugs?

Workman, Paul; Draetta, Giulio F; Schellens, Jan H M; Bernards, René

(2017) Cell, volume 168, issue 4, pp. 579 - 583

(Article)

Abstract

The spiraling cost of new drugs mandates a fundamentally different approach to keep lifesaving therapies affordable for cancer patients. We call here for the formation of new relationships between academic drug discovery centers and commercial partners, which can accelerate the development of truly transformative drugs at sustainable prices.

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Keywords: Antineoplastic Agents, Drug Approval, Drug Costs, Drug Discovery, Health Care Costs, Humans, Neoplasms, United States, Journal Article

DOI: https://doi.org/10.1016/j.cell.2017.01.034

ISSN: 0092-8674

Publisher: Cell Press

(Peer reviewed)

See more statistics about this item